| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |